Showing results (421-430 of 542) with videos related to
Sort By:
Pageof 55
Cancers|May 16, 2023
Engagement, Advance Care Planning, and Hospice Use in a Telephonic Nurse-Led Palliative Care Program for Persons Living with Advanced CancerRebecca Liddicoat Yamarik, Laraine Ann Chiu, Mara Flannery, et al.JCO Oncology Practice|July 1, 2026
Patient Engagement With an Electronic Patient-Reported Outcomes Tool Evaluating Hospital Discharge Readiness After Cancer SurgeryJennifer R Cracchiolo, Richard S Matulewicz, Norma E Farrow, et al.European Urology Focus|September 4, 2021
Health-related Quality of Life at the SPARTAN Final Analysis of Apalutamide for Nonmetastatic Castration-resistant Prostate Cancer Patients Receiving Androgen Deprivation TherapyStéphane Oudard, Boris Hadaschik, Fred Saad, et al.MDM Policy & Practice|May 15, 2026
Developing a Novel Values Elicitation Measure for Clinical Use in Older Adults with Hematologic Malignancies: Values-HMDaniel R Richardson, Allison M Deal, Carl J Mhina, et al.Frontiers in Oncology|November 10, 2022
Quality of life and function after rectal cancer surgery with and without sphincter preservationEmmanouil P Pappou, Larissa K Temple, Sujata Patil, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
American Society of Clinical Oncology/National Comprehensive Cancer Network Quality MeasuresChristopher E Desch, Kristen K McNiff, Eric C Schneider, et al.JAMA Oncology|June 13, 2024
Home Time Among Older Adults With Acute Myeloid Leukemia Following ChemotherapyDaniel R Richardson, Xi Zhou, Katherine Reeder-Hayes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Moving beyond the hazard ratio in quantifying the between-group difference in survival analysisHajime Uno, Brian Claggett, Lu Tian, et al.The Permanente Journal|August 28, 2023
Real-World Use of Electronic Patient-Reported Outcome (ePRO) Tools Integrated in the Electronic Medical Record During Radiation Therapy for Head and Neck Cancer: Feasibility StudyJed A Katzel, Stephen K Van Den Eeden, Raymond Liu, et al.The Lancet. Oncology|October 1, 2013
Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported outcome results of a randomised phase 3 trialEthan Basch, Karen Autio, Charles J Ryan, et al.Pageof 55